Global medtech company Baxter International Inc. will locate its new U.S. distribution operation hub in Byhalia, Mississippi. The $11.6 million project is expected to create 105 jobs in Marshall County.

The 851,000-square-foot facility includes upgraded technology and expanded warehousing capabilities that will enable the company to better meet the needs of its patients and customers.

“Expanding our operations and logistics hub helps Baxter provide sustainable supply for our hospital and dialysis customers, which is especially critical during the ongoing pandemic. Marshall County is an ideal location for our operations, and we are excited to expand our presence in Mississippi by becoming a part of the Byhalia community,” James Borzi, Baxter Senior Vice President and Chief Supply Chain Officer said.

As an incentive, the Mississippi Development Authority (MDA) provided assistance for equipment relocation and installation and building construction. Marshall County and the Tennessee Valley Authority also are assisting with the project.

“Economic development in Mississippi has gotten off to a phenomenal start in 2022, and today we continue that trend with the announcement that Baxter has located distribution operations in Marshall County, a project that has already created more than 100 new jobs for the area’s workforce. The Marshall County facility will be Baxter’s second in the state, so the company is already aware of the numerous business advantages offered by a Mississippi location, such as our strong business environment and productive workforce. We look forward to the company’s continued growth and thank our partners at the Marshall County Industrial Development Authority and Marshall County for working with us to win this project for Mississippi,” MDA Interim Executive Director Laura Hipp noted.

Baxter provides leading healthcare solutions in diagnostics, acute, hospital, nutritional, renal and surgical care. The company’s products and therapies can be found throughout physician offices, hospitals and clinics, as well as in patients’ homes.